2012: Cardiovascular disease causes almost half of all deaths in the European Union

Cardiovascular disease causes almost half of all deaths in the European Union

In past years, we have seen a growing occurrence of cardiovascular disease (CVD), which currently is responsible for 47% of all deaths in Europe. As demonstrated by ever-growing costs that currently total around €195 billion € (157 billion £), measures to reverse this trend are essential.

In light of these statistics, it is necessary to focus on developing preventive solutions such as improving dietary habits and increasing consumption of foods containing bioactive substances beneficial for the cardiovascular system. ‘Beneficial Effects of dietary bioactive peptides and polyphenols on cardiovascular health in humans’ (BACCHUS) will develop tools and resources facilitating the generation of robust and exploitable scientific evidence that support a cause-and-effect relationship between consumption of bioactive peptides and polyphenols, and beneficial physiological effects related to cardiovascular health in humans (e.g. reducing high blood pressure). BACCHUS will also support European SMEs creating new food products, which boost cardiovascular health, with scientific evidence and tools essential for obtaining favourable opinions from EFSA for health claims dossiers.

To achieve this, the BACCHUS consortium has assembled 16 SMEs, which are involved in developing food products and pursuing health claims, and 12 leading research organisations with expertise in health claims legislation, and food and health research. BACCHUS is focusing on the positive effects of bioactive substances found in foods that are common in European diets including apple, chokeberry, sweet oranges, pomegranate, cured pork products and wheat. For more information visit: http://bacchus-fp7.eu .

BACCHUS is a collaborative project under the 7th Framework Program of the European Commission, funded by Specific Programme ‘Cooperation’ – Research Theme: ‘Food, agriculture and fisheries, and biotechnology’, funded within the FP7-KBBE-2012-6-single-stage, under Grant Agreement no 312090. The €6M accessibility research and development effort funding brings together 28 Beneficiaries, led by the Institute of Food Research (UK).

Notes to Editors:

The 28 beneficiaries of BACCHUS are: Institute of Food Research (UK), University of Leeds (UK), Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TR), Agencia estatal consejo superior de investigaciones (ES), NOFIMA (Norway), University College Cork (IE), Institut za Medicinska Istra Ivanja (Serbia), Universita di Bologna (IT), Universiteit Gent (BE), Vlaamse Instelling voor Technologisch Onderzoek NV (BE), LGC Ltd. (UK), Helsingin Yliopisto (FI), British Nutrition Foundation (UK), EuroFIR AISBL (BE), Pamida International SRO (SK), CREME Software Ltd. (IE), Valdycomer SA (ES), Industrias Carnicas VAQUERO (ES), Wagralim ASBL (BE), Critical Processes Ltd. (UK), Coressence Ltd. (UK), Laboratorios Admira sl. (ES), Bioaesis srl. (IT), Kamut Enterprises of Europe BVBA (BE), Bioactor BV (NL), Prodigest (BE), Nutrika doo (Serbia) and Fundacion Universitaria San Antonio de Cartagena (ES)

Project coordinator: Institute of Food Research
Lead researcher(s): Paul Kroon and Paul Finglas

European cardiovascular disease statistics 2012: http://www.ehnheart.org/cvd-statistics.html CVD causes 47% of all deaths in Europe and 40% in the EU.

Overall CVD is estimated to cost the EU economy €195 billion a year.

Of the total cost of CVD in the EU, around 54% is due to health care costs, 24% due to productivity losses and 22% due to the informal care of people with CVD.


Andrew Chapple, press officer – Norwich, United Kingdom:
T +44 (0)1603 251490
M +44 (0)7713 087883
E andrew.chapple@ifr.ac.uk

Martin Haranta, communication manager – Kysucké Nové Mesto, Slovak Republic
M: +421 917 858 838
E: martin.haranta@pamidainternational.com